<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348852</url>
  </required_header>
  <id_info>
    <org_study_id>EA4/017/16</org_study_id>
    <nct_id>NCT03348852</nct_id>
  </id_info>
  <brief_title>Association Between Functional Changes in the Brain and the Perception of Pain in Patients With Inflammatory Bowel Diseases (IBD) - Measured With Functional Magnetic Resonance Imaging.</brief_title>
  <official_title>Assoziation Zwischen Funktionellen Gehirnveränderungen Und Der Schmerzwahrnehmung Bei Patienten Mit Chronisch entzündlicher Darmerkrankung Mittels fMRT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the study the investigators aim to test whether transcranial direct current stimulation
      (tDCS)-induced pain reduction is in association with functional changes in the brain measured
      with functional magnetic resonance imaging (fMRI) in patients with chronic inflammatory bowel
      diseases (IBD).

      Hypothesis: Transcranial direct current stimulation can reduce the perception of pain in
      patients with chronic inflammatory bowel diseases, which is in association with changes in
      the brain measured via fMRI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 24, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional and/or structural changes in the brain measured with cerebral MRI</measure>
    <time_frame>2 week</time_frame>
    <description>Participants will be followed for 2 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in pain measured with visual analogue scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>Participants will be followed for 2 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in perception of pain measured with an algometer (pain pressure threshold)</measure>
    <time_frame>2 weeks</time_frame>
    <description>Participants will be followed for 2 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in questionnaire &quot;quality of life&quot;</measure>
    <time_frame>2 weeks</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in functional symptoms</measure>
    <time_frame>2 weeks</time_frame>
    <description>Questionnarie: irritable bowel syndrome - severity scoring system (IBS-SSS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in activity indices</measure>
    <time_frame>2 weeks</time_frame>
    <description>Harvey-Bradshaw Index (HBI) or simple clinical colitis activity index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in pain catastophizing scale</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in inflammation biomarker (blood - C-reactive protein)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in inflammation biomarker (stool - calprotectin)</measure>
    <time_frame>2 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Inflammatory Bowel Diseases</condition>
  <arm_group>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Active transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial direct current stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>Device: Transcranial direct current stimulation Transcranial direct current stimulation over the motor cortex.</description>
    <arm_group_label>Active tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
    <other_name>tDCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inflammatory bowel disease

          -  Chronic pain (more than 3 months)

          -  Pain (VAS &gt; 3/10)

        Exclusion Criteria:

          -  Contraindication to transcranial direct current stimulation

          -  Contraindications to functional magnetic resonance imaging (fMRI)

          -  Pregnancy

          -  Sever internal or psychiatric condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Magdalena S Prüß-Volz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Magdalena S Prüß-Volz, MD</last_name>
    <phone>+493084452718</phone>
    <email>magdalena.pruess@charite.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Charité University Medicine</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdalena S Prüß-Volz, MD</last_name>
      <phone>+493084452718</phone>
      <email>magdalena.pruess@charite.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Magdalena S. Prüß née Volz</investigator_full_name>
    <investigator_title>Dr. med. Magdalena Sarah Prüß (geb. Volz)</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

